NCT02170623View on ClinicalTrials.gov

Bioavailability of BIBR 953 ZW After Administration of BIBR 1048 MS in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

April 30, 2002

Conditions
Healthy
Interventions
DRUG

BIBR 1048 MS Capsule I

25 mg BIBR 1048 MS

DRUG

BIBR 1048 MS Capsule K

50 mg BIBR 1048 MS

DRUG

Pantoprazole

40 mg pantoprazole

DRUG

BIBR 1048 MS drinking solution

50 mg BIBR 1048 MS powder plus solution

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY